The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis
dc.contributor.author | Lie, Ingrid Anne | |
dc.contributor.author | Wesnes, Kristin | |
dc.contributor.author | Kvistad, Silje S. | |
dc.contributor.author | Brouwer, Iman | |
dc.contributor.author | Wergeland, Stig | |
dc.contributor.author | Holmøy, Trygve | |
dc.contributor.author | Midgard, Rune | |
dc.contributor.author | Bru, Alla Nikolajevna S | |
dc.contributor.author | Edland, Astrid | |
dc.contributor.author | Eikeland, Randi | |
dc.contributor.author | Gosal, Sonia | |
dc.contributor.author | Harbo, Hanne-Cathrin Flinstad | |
dc.contributor.author | Kleveland, Grethe | |
dc.contributor.author | Sørenes, Yvonne | |
dc.contributor.author | Øksendal, Nina | |
dc.contributor.author | Barkhof, Frederik | |
dc.contributor.author | Vrenken, Hugo | |
dc.contributor.author | Myhr, Kjell-Morten | |
dc.contributor.author | Bø, Lars | |
dc.contributor.author | Torkildesen, Øivind | |
dc.date.accessioned | 2023-01-12T13:36:00Z | |
dc.date.available | 2023-01-12T13:36:00Z | |
dc.date.created | 2022-08-11T16:07:13Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Lie, I. A., Wesnes, K., Kvistad, S. S., Brouwer, I., Wergeland, S., Holmøy, T., Midgard, R., Bru, A. N. S., Edland, A., Eikeland, R., Gosal, S., Harbo, H.- C. F., Kleveland, G., Sørenes, Y., Øksendal, N., Barkhof, F., Vrenken, H., Myhr, K.- M., Bø, L. & Torkildesen, Ø. (2022). The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis. Neurology: Neuroimmunology and neuroinflammation, 9 (5). | en_US |
dc.identifier.issn | 2332-7812 | |
dc.identifier.uri | https://hdl.handle.net/11250/3043107 | |
dc.description.abstract | The relationship between smoking, long-term brain atrophy, and clinical disability in patients with multiple sclerosis (MS) is unclear. Here, we assessed long-term effects of smoking by evaluating MRI and clinical outcome measures after 10 years in smoking and nonsmoking patients with relapsing-remitting MS (RRMS). | en_US |
dc.language.iso | eng | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.no | * |
dc.title | The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis | en_US |
dc.title.alternative | The Effect of Smoking on Long-term Gray Matter Atrophy and Clinical Disability in Patients with Relapsing-Remitting Multiple Sclerosis | en_US |
dc.type | Peer reviewed | en_US |
dc.type | Journal article | en_US |
dc.description.version | publishedVersion | en_US |
dc.rights.holder | © 2022 The Author(s) | en_US |
dc.subject.nsi | VDP::Medisinske Fag: 700::Klinisk medisinske fag: 750::Nevrologi: 752 | en_US |
dc.source.volume | 9 | en_US |
dc.source.journal | Neurology: Neuroimmunology and neuroinflammation | en_US |
dc.source.issue | 5 | en_US |
dc.identifier.doi | https://doi.org/10.1212/NXI.0000000000200008 | |
dc.identifier.cristin | 2042531 | |
cristin.qualitycode | 1 |